Literature DB >> 11087788

Novel mutations in spastin gene and absence of correlation with age at onset of symptoms.

A Hentati1, H X Deng, H Zhai, W Chen, Y Yang, W Y Hung, A C Azim, S Bohlega, R Tandan, C Warner, N G Laing, F Cambi, H Mitsumoto, R P Roos, R M Boustany, M Ben Hamida, F Hentati, T Siddique.   

Abstract

Autosomal dominant hereditary spastic paraplegia is genetically heterogeneous, with at least five loci identified by linkage analysis. Recently, mutations in spastin were identified in SPG4, the most common locus for dominant hereditary spastic paraplegia that was previously mapped to chromosome 2p22. We identified five novel mutations in the spastin gene in five families with SPG4 mutations from North America and Tunisia and showed the absence of correlation between the predicted mutant spastin protein and age at onset of symptoms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11087788     DOI: 10.1212/wnl.55.9.1388

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

1.  Detection of a novel SPG4-nonsense-mutation in a large German pedigree with pure spastic paraplegia.

Authors:  K Bürk; A Dalski; S Purmann; C Zühlke
Journal:  J Neurol       Date:  2005-03-03       Impact factor: 4.849

2.  No correlation between amount of aberrant transcript and severity of phenotype in hereditary spastic paraplegia patients with a c.1242A > G splice mutation in the SPG4 gene.

Authors:  Simone M Sauter; Nadine Dörwald; Wolfgang Engel; Jürgen Neesen
Journal:  J Neurol       Date:  2005-12-13       Impact factor: 4.849

3.  Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia.

Authors:  I K Svenson; A E Ashley-Koch; P C Gaskell; T J Riney; W J Cumming; H M Kingston; E L Hogan; R M Boustany; J M Vance; M A Nance; M A Pericak-Vance; D A Marchuk
Journal:  Am J Hum Genet       Date:  2001-04-16       Impact factor: 11.025

4.  Spinal cord magnetic resonance imaging in autosomal dominant hereditary spastic paraplegia.

Authors:  P Hedera; O P Eldevik; P Maly; S Rainier; J K Fink
Journal:  Neuroradiology       Date:  2005-09-06       Impact factor: 2.804

5.  Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases.

Authors:  C Depienne; C Tallaksen; J Y Lephay; B Bricka; S Poea-Guyon; B Fontaine; P Labauge; A Brice; A Durr
Journal:  J Med Genet       Date:  2005-07-31       Impact factor: 6.318

6.  Spastin, the most commonly mutated protein in hereditary spastic paraplegia interacts with Reticulon 1 an endoplasmic reticulum protein.

Authors:  Ashraf U Mannan; Johann Boehm; Simone M Sauter; Anne Rauber; Paula C Byrne; Juergen Neesen; Wolfgang Engel
Journal:  Neurogenetics       Date:  2006-04-07       Impact factor: 2.660

7.  Expansion of mutation spectrum, determination of mutation cluster regions and predictive structural classification of SPAST mutations in hereditary spastic paraplegia.

Authors:  Moneef Shoukier; Juergen Neesen; Simone M Sauter; Loukas Argyriou; Nadine Doerwald; D V Krishna Pantakani; Ashraf U Mannan
Journal:  Eur J Hum Genet       Date:  2008-08-13       Impact factor: 4.246

Review 8.  Science in motion: common molecular pathological themes emerge in the hereditary spastic paraplegias.

Authors:  E Reid
Journal:  J Med Genet       Date:  2003-02       Impact factor: 6.318

9.  REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31.

Authors:  Christian Beetz; Rebecca Schüle; Tine Deconinck; Khanh-Nhat Tran-Viet; Hui Zhu; Berry P H Kremer; Suzanna G M Frints; Wendy A G van Zelst-Stams; Paula Byrne; Susanne Otto; Anders O H Nygren; Jonathan Baets; Katrien Smets; Berten Ceulemans; Bernard Dan; Narasimhan Nagan; Jan Kassubek; Sven Klimpe; Thomas Klopstock; Henning Stolze; Hubert J M Smeets; Constance T R M Schrander-Stumpel; Michael Hutchinson; Bart P van de Warrenburg; Corey Braastad; Thomas Deufel; Margaret Pericak-Vance; Ludger Schöls; Peter de Jonghe; Stephan Züchner
Journal:  Brain       Date:  2008-03-05       Impact factor: 13.501

10.  Usefulness of comprehensive targeted multigene panel sequencing for neuromuscular disorders in Korean patients.

Authors:  Jihye Park; Hyun Mi Oh; Hye Jung Park; Ah-Ra Cho; Dong-Woo Lee; Ja-Hyun Jang; Dae-Hyun Jang
Journal:  Mol Genet Genomic Med       Date:  2019-09-01       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.